Cowen analyst Doug Schenkel raised the price target on Tandem Diabetes Care (NASDAQ: TNDM) to $60.00 (from $40.00) while ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst EPS Change Analyst EPS View Analyst PT Change

Tandem Diabetes Care (TNDM) PT Raised to $58 at StifelFebruary 27, 2019 7:59 AM Tandem Diabetes Care (TNDM) PT Raised to $67 at Piper JaffrayFebruary 27, 2019 3:03 AM Tandem Diabetes (TNDM) Confirms Succession Plan for CEO and BoardFebruary 26, 2019 4:52 PM Tandem Diabetes (TNDM) Tops Q4 EPS by 22c, Revenues Beat; Offers FY19 Revenue Guidance Above ConsensusFebruary 26, 2019 4:11 PM Tandem Diabetes Care Announces Succession Plan for Chief Executive Officer and Board of DirectorsFebruary 26, 2019 4:07 PM